Skip to main content

Peer Review reports

From: Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells

Original Submission
30 Nov 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
25 Mar 2022 Reviewed Reviewer Report
29 Apr 2022 Reviewed Reviewer Report
11 Jul 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 3
11 Jul 2022 Submitted Manuscript version 3
19 Jul 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 4
19 Jul 2022 Submitted Manuscript version 4
28 Jul 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 5
28 Jul 2022 Submitted Manuscript version 5
2 Aug 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 6
2 Aug 2022 Submitted Manuscript version 6
18 Aug 2022 Reviewed Reviewer Report
28 Aug 2022 Author responded Author comments - LaMonica V. Stewart
Resubmission - Version 7
28 Aug 2022 Submitted Manuscript version 7
14 Sep 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
19 Sep 2022 Editorially accepted
29 Sep 2022 Article published 10.1186/s12885-022-10115-3

You can find further information about peer review here.

Back to article page